Original from: MGI Tech
MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and Asia Pathogen Genomics Initiative (“Asia PGI”) have recently announced collaboration aimed at enhancing pathogen genomics sequencing efforts across Asia. This collaboration underscores a shared commitment to supporting public health initiatives through advanced life science technology.
As part of this collaboration, MGI and Asia PGI will jointly democratize the pathogen genomics sequencing technology in Singapore and across Asia. The collaborative efforts will include hosting webinars to provide practical knowledge in pathogen genomics sequencing and delivering hands-on technical training to institutions and laboratories aimed at improving capacity development in pathogen detection.
In addition, MGI also announced the launch of the MGI APAC Pandemic Preparedness Program (PPP) to strengthen the capabilities of genomics institutions and laboratories in pathogen surveillance. In collaboration with Asia PGI, the PPP aims to broaden the scope of pathogen surveillance solutions available to partner countries. The program offers a differentiated and sustainable alternative, focusing on application-centric and workflow-driven solutions. For example, it supports the development of equitable, effective, relevant, and validated workflow solutions to address acute infectious diseases.
"At Asia Pathogen Genomics Initiative, we believe that equitable access to pathogen genomic sequencing is fundamental to strengthening health security across South and Southeast Asia," said Paul Pronyk from Asia PGI. "By collaborating with industry partners such as MGI, we are committed to ensuring that all communities in our region benefit from the latest advances in pathogen genomics – enabling early detection, informed response and ultimately, a healthier future for all."
"We are proud to partner with Asia PGI to accelerate the application of cutting-edge sequencing technology in pathogen genomics," said Roy Tan, General Manager of MGI Asia Pacific. "Pathogen control is a pressing challenge for many countries in Asia. This partnership aims to improve the accessibility of pathogen genomics, empowering researchers and public health professionals in their fight against infectious diseases."
In response to the growing demand for rapid and precise detection of infectious diseases, MGI has developed a diverse array of comprehensive products for various applications, including metagenomic sequencing, targeted sequencing, and whole genome sequencing of pathogenic microorganisms. Looking ahead, MGI is committed to continuing its innovation, providing automated, convenient, and efficient core tools for pathogen identification, drug resistance analysis, and traceability.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.